Recent News

• 02.13.2026 - Iterum Therapeutics Provides Business Update
• 12.23.2025 - Iterum Therapeutics Provides Business Update
• 12.17.2025 - Iterum Therapeutics Provides Business Update
• 12.05.2025 - Iterum Therapeutics Provides Business Update
• 11.24.2025 - Iterum Therapeutics Provides Business Update
• 11.14.2025 - Iterum Therapeutics Reports Third Quarter 2025 Financial Results
• 11.07.2025 - Iterum Therapeutics to Report Third Quarter 2025 Financial Results on Friday, November 14, 2025
• 10.14.2025 - Iterum Therapeutics to Present Data at IDWeek 2025
• 10.14.2025 - Iterum Therapeutics to Present Data at IDWeek 2025
• 09.19.2025 - Iterum Therapeutics Provides Business Update

Recent Filings

• 01.26.2026 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 01.02.2026 - DEF 14A Other definitive proxy statements
• 12.23.2025 - PRE 14A Other preliminary proxy statements
• 12.12.2025 - 8-K Current report
• 11.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.14.2025 - EX-99.1 EX-99.1
• 11.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.14.2025 - 8-K Current report
• 10.16.2025 - 8-K Current report
• 10.16.2025 - 424B5 Prospectus [Rule 424(b)(5)]